Focus Partners Wealth
GOSS icon

Focus Partners Wealth’s Gossamer Bio GOSS Stock Holding History

Focus Partners Wealth’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Buy
+73,013
New +$115K ﹤0.01% 2607
2025
Q4 		– Sell
-1,325,198
Closed -$3.49M – 2738
2025
Q3 		$3.49M Buy
1,325,198
+175,198
+15% +$386K 0.01% 858
2025
Q2 		$1.41M Buy
1,150,000
+450,000
+64% +$491K ﹤0.01% 1008
2025
Q1 		$770K Buy
+700,000
New +$809K ﹤0.01% 1163

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Focus Partners Wealth's GOSS Position: Q1 2026 in Review

Focus Partners Wealth opened a new position in Gossamer Bio (GOSS) in Q1 2026: 73,013 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #2607 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in GOSS as recently as Q3 2025.

Focus Partners Wealth first reported a position in GOSS in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.49M in Q3 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Focus Partners Wealth held 73,013 shares of Gossamer Bio worth $24K as of Q1 2026.
  • Gossamer Bio was a new Focus Partners Wealth position in Q1 2026.
  • Gossamer Bio made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2607 holding.
  • Focus Partners Wealth first reported a position in Gossamer Bio in Q1 2025 and has held it in 4 quarters since.
  • Focus Partners Wealth's Gossamer Bio position peaked at $3.49M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.